Ki-67 Index Provides Long-Term Survival Information for Early-Stage HER2-Low-Positive Breast Cancer: A Single-Institute Retrospective Analysis

AIM: It has been reported that more than half of breast cancer (BC) could be identified as HER2-low-positive, which might be a distinct subtype. But the results are controversial. We aim to compare the survival outcomes between HER2-low-positive and HER2-0 BC with Asian women based on HR status or K...

Descripción completa

Detalles Bibliográficos
Autores principales: Qi, Wei-Xiang, Chen, Lingyan, Cao, Lu, Xu, Cheng, Cai, Gang, Chen, Jiayi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489376/
https://www.ncbi.nlm.nih.gov/pubmed/36147446
http://dx.doi.org/10.1155/2022/4364151

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9489376/
https://www.ncbi.nlm.nih.gov/pubmed/36147446
http://dx.doi.org/10.1155/2022/4364151

Ejemplares similares